871 related articles for article (PubMed ID: 29378883)
1. Endopeptidase PepO Regulates the SpeB Cysteine Protease and Is Essential for the Virulence of Invasive M1T1 Streptococcus pyogenes.
Brouwer S; Cork AJ; Ong CY; Barnett TC; West NP; McIver KS; Walker MJ
J Bacteriol; 2018 Apr; 200(8):. PubMed ID: 29378883
[No Abstract] [Full Text] [Related]
2. Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB.
Aziz RK; Pabst MJ; Jeng A; Kansal R; Low DE; Nizet V; Kotb M
Mol Microbiol; 2004 Jan; 51(1):123-34. PubMed ID: 14651616
[TBL] [Abstract][Full Text] [Related]
3. An amino-terminal signal peptide of Vfr protein negatively influences RopB-dependent SpeB expression and attenuates virulence in Streptococcus pyogenes.
Shelburne SA; Olsen RJ; Makthal N; Brown NG; Sahasrabhojane P; Watkins EM; Palzkill T; Musser JM; Kumaraswami M
Mol Microbiol; 2011 Dec; 82(6):1481-95. PubMed ID: 22040048
[TBL] [Abstract][Full Text] [Related]
4. Leaderless secreted peptide signaling molecule alters global gene expression and increases virulence of a human bacterial pathogen.
Do H; Makthal N; VanderWal AR; Rettel M; Savitski MM; Peschek N; Papenfort K; Olsen RJ; Musser JM; Kumaraswami M
Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8498-E8507. PubMed ID: 28923955
[TBL] [Abstract][Full Text] [Related]
5. Trigger for group A streptococcal M1T1 invasive disease.
Cole JN; McArthur JD; McKay FC; Sanderson-Smith ML; Cork AJ; Ranson M; Rohde M; Itzek A; Sun H; Ginsburg D; Kotb M; Nizet V; Chhatwal GS; Walker MJ
FASEB J; 2006 Aug; 20(10):1745-7. PubMed ID: 16790522
[TBL] [Abstract][Full Text] [Related]
6. From transcription to activation: how group A streptococcus, the flesh-eating pathogen, regulates SpeB cysteine protease production.
Carroll RK; Musser JM
Mol Microbiol; 2011 Aug; 81(3):588-601. PubMed ID: 21707787
[TBL] [Abstract][Full Text] [Related]
7. The majority of 9,729 group A streptococcus strains causing disease secrete SpeB cysteine protease: pathogenesis implications.
Olsen RJ; Raghuram A; Cantu C; Hartman MH; Jimenez FE; Lee S; Ngo A; Rice KA; Saddington D; Spillman H; Valson C; Flores AR; Beres SB; Long SW; Nasser W; Musser JM
Infect Immun; 2015 Dec; 83(12):4750-8. PubMed ID: 26416912
[TBL] [Abstract][Full Text] [Related]
8. Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group A streptococcal infection.
Ashbaugh CD; Wessels MR
Infect Immun; 2001 Nov; 69(11):6683-8. PubMed ID: 11598038
[TBL] [Abstract][Full Text] [Related]
9. The Streptococcal Protease SpeB Antagonizes the Biofilms of the Human Pathogen Staphylococcus aureus USA300 through Cleavage of the Staphylococcal SdrC Protein.
Carothers KE; Liang Z; Mayfield J; Donahue DL; Lee M; Boggess B; Ploplis VA; Castellino FJ; Lee SW
J Bacteriol; 2020 May; 202(11):. PubMed ID: 32205460
[No Abstract] [Full Text] [Related]
10. Neutrophils select hypervirulent CovRS mutants of M1T1 group A Streptococcus during subcutaneous infection of mice.
Li J; Liu G; Feng W; Zhou Y; Liu M; Wiley JA; Lei B
Infect Immun; 2014 Apr; 82(4):1579-90. PubMed ID: 24452689
[TBL] [Abstract][Full Text] [Related]
11. Group A streptococcal cysteine protease cleaves epithelial junctions and contributes to bacterial translocation.
Sumitomo T; Nakata M; Higashino M; Terao Y; Kawabata S
J Biol Chem; 2013 May; 288(19):13317-24. PubMed ID: 23532847
[TBL] [Abstract][Full Text] [Related]
12. IgG protease Mac/IdeS is not essential for phagocyte resistance or mouse virulence of M1T1 group A Streptococcus.
Okumura CY; Anderson EL; Döhrmann S; Tran DN; Olson J; von Pawel-Rammingen U; Nizet V
mBio; 2013 Jul; 4(4):. PubMed ID: 23900173
[TBL] [Abstract][Full Text] [Related]
13. [Detection of pyrogenic exotoxin SpeA, SpeB and SpeC genes in Chilean streptococci isolates and their association with clinical manifestations].
Ulloa MT; Giglio MS; Porte L; Santa Cruz A; McNab P; Fica A; Pinto ME; Kawaguchi K; Carmi A
Rev Med Chil; 2000 Jan; 128(1):27-34. PubMed ID: 10883519
[TBL] [Abstract][Full Text] [Related]
14. Null Mutations of Group A Streptococcus Orphan Kinase RocA: Selection in Mouse Infection and Comparison with CovS Mutations in Alteration of In Vitro and In Vivo Protease SpeB Expression and Virulence.
Feng W; Minor D; Liu M; Li J; Ishaq SL; Yeoman C; Lei B
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795364
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of streptolysin S and streptococcal pyrogenic exotoxin B on the mouse model of group A streptococcal infection.
Hung CH; Tsao N; Zeng YF; Lu SL; Chuan CN; Lin YS; Wu JJ; Kuo CF
Med Microbiol Immunol; 2012 Aug; 201(3):357-69. PubMed ID: 22610375
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains.
Lukomski S; Sreevatsan S; Amberg C; Reichardt W; Woischnik M; Podbielski A; Musser JM
J Clin Invest; 1997 Jun; 99(11):2574-80. PubMed ID: 9169486
[TBL] [Abstract][Full Text] [Related]
17. Genomic Characterization of a Pattern D Streptococcus pyogenes emm53 Isolate Reveals a Genetic Rationale for Invasive Skin Tropicity.
Bao YJ; Liang Z; Mayfield JA; Donahue DL; Carothers KE; Lee SW; Ploplis VA; Castellino FJ
J Bacteriol; 2016 Jun; 198(12):1712-24. PubMed ID: 27044623
[TBL] [Abstract][Full Text] [Related]
18. SpeB-Spi: a novel protease-inhibitor pair from Streptococcus pyogenes.
Kagawa TF; O'toole PW; Cooney JC
Mol Microbiol; 2005 Aug; 57(3):650-66. PubMed ID: 16045611
[TBL] [Abstract][Full Text] [Related]
19. A chemokine-degrading extracellular protease made by group A Streptococcus alters pathogenesis by enhancing evasion of the innate immune response.
Sumby P; Zhang S; Whitney AR; Falugi F; Grandi G; Graviss EA; Deleo FR; Musser JM
Infect Immun; 2008 Mar; 76(3):978-85. PubMed ID: 18174342
[TBL] [Abstract][Full Text] [Related]
20. The fibrinogen-binding M1 protein reduces pharyngeal cell adherence and colonization phenotypes of M1T1 group A Streptococcus.
Anderson EL; Cole JN; Olson J; Ryba B; Ghosh P; Nizet V
J Biol Chem; 2014 Feb; 289(6):3539-46. PubMed ID: 24356958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
